Detalhe da pesquisa
1.
Yap governs a lineage-specific neuregulin1 pathway-driven adaptive resistance to RAF kinase inhibitors.
Mol Cancer
; 21(1): 213, 2022 12 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36476495
2.
Transposon mutagenesis identifies chromatin modifiers cooperating with Ras in thyroid tumorigenesis and detects ATXN7 as a cancer gene.
Proc Natl Acad Sci U S A
; 114(25): E4951-E4960, 2017 06 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-28584132
3.
STAT3 negatively regulates thyroid tumorigenesis.
Proc Natl Acad Sci U S A
; 109(35): E2361-70, 2012 Aug 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-22891351
4.
Thyrotrophin receptor signaling dependence of Braf-induced thyroid tumor initiation in mice.
Proc Natl Acad Sci U S A
; 108(4): 1615-20, 2011 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-21220306
5.
Telomerase reactivation induces progression of mouse Braf V600E -driven thyroid cancers without telomere lengthening.
bioRxiv
; 2023 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36747657
6.
Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy.
Clin Cancer Res
; 29(8): 1620-1630, 2023 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36780190
7.
Telomerase Upregulation Induces Progression of Mouse BrafV600E-Driven Thyroid Cancers and Triggers Nontelomeric Effects.
Mol Cancer Res
; 21(11): 1163-1175, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37478162
8.
Association of Treatment Strategies and Tumor Characteristics With Overall Survival Among Patients With Anaplastic Thyroid Cancer: A Single-Institution 21-Year Experience.
JAMA Otolaryngol Head Neck Surg
; 149(4): 300-309, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36757708
9.
Endogenous expression of Hras(G12V) induces developmental defects and neoplasms with copy number imbalances of the oncogene.
Proc Natl Acad Sci U S A
; 106(19): 7979-84, 2009 May 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-19416908
10.
Characterization of Subtypes of BRAF-Mutant Papillary Thyroid Cancer Defined by Their Thyroid Differentiation Score.
J Clin Endocrinol Metab
; 107(4): 1030-1039, 2022 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34897468
11.
BRAFV600E Induction in Thyrocytes Triggers Important Changes in the miRNAs Content and the Populations of Extracellular Vesicles Released in Thyroid Tumor Microenvironment.
Biomedicines
; 10(4)2022 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35453506
12.
BRAFV600E Expression in Thyrocytes Causes Recruitment of Immunosuppressive STABILIN-1 Macrophages.
Cancers (Basel)
; 14(19)2022 Sep 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36230610
13.
Mitonuclear genotype remodels the metabolic and microenvironmental landscape of Hürthle cell carcinoma.
Sci Adv
; 8(25): eabn9699, 2022 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35731870
14.
Enhancing Radioiodine Incorporation in BRAF-Mutant, Radioiodine-Refractory Thyroid Cancers with Vemurafenib and the Anti-ErbB3 Monoclonal Antibody CDX-3379: Results of a Pilot Clinical Trial.
Thyroid
; 32(3): 273-282, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35045748
15.
Co-inhibition of SMAD and MAPK signaling enhances 124I uptake in BRAF-mutant thyroid cancers.
Endocr Relat Cancer
; 28(6): 391-402, 2021 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33890869
16.
SWI/SNF Complex Mutations Promote Thyroid Tumor Progression and Insensitivity to Redifferentiation Therapies.
Cancer Discov
; 11(5): 1158-1175, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33318036
17.
The RET kinase inhibitor NVP-AST487 blocks growth and calcitonin gene expression through distinct mechanisms in medullary thyroid cancer cells.
Cancer Res
; 67(14): 6956-64, 2007 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17638907
18.
Mouse Models as a Tool for Understanding Progression in BrafV600E-Driven Thyroid Cancers.
Endocrinol Metab (Seoul)
; 34(1): 11-22, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30784243
19.
Establishment and Characterization of Four Novel Thyroid Cancer Cell Lines and PDX Models Expressing the RET/PTC1 Rearrangement, BRAFV600E, or RASQ61R as Drivers.
Mol Cancer Res
; 17(5): 1036-1048, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30733375
20.
Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid Cancers.
J Clin Endocrinol Metab
; 104(5): 1417-1428, 2019 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30256977